The country president of Novartis Czech Republic explains the strategy that led the affiliate to become the number one pharmaceutical company in the Czech market, highlighting the significance of her team in accomplishing 8.4 percent market share. Furthermore, she shares news of recent significant investments into clinical trials and a shared service center.
Novartis enjoys 8.4 percent market share in the Czech Republic, what was your strategy that led the Czech affiliate to this great success?
As a worldwide industry, we’re at the vanguard of revolution on how we conduct business, the opportunities offered by big data are present and we need to tap into this immense potential.
